Delivery Order SPE2DB22D2206-SPE2DB25FJH72
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Onfil 10 mg tablets (100 count) with a ceiling value of $3,064.78. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,422.19 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded contract utilizes firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in Conshohocken, PA 19428....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for Onfil 10 mg tablets (100-count units) with a ceiling value of $11,281.66. This firm fixed-price delivery order, which represents a non-competitive set-aside contract, is scheduled for ultimate completion by August 1, 2025, with performance occurring at the awardee's Conshohocken facility. The contract was issued as a child order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Onfil 10 mg tablets (100 count) under a firm fixed price contract with a ceiling value of $9,377.00. This is a competitively awarded, non-set-aside delivery order to be completed by August 15, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract, this delivery order derives from AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $5,525.16 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Onfil 10 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with performance through July 29, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $7,436.43 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Onfiant 10 mg, with delivery expected by July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,911.94 to AmerisourceBergen Drug Corp for 100 tablets of Onfivamide 10 mg, with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,586.87 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $27,841.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award was issued on July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,883.05 to AmerisourceBergen Drug Corp on August 11, 2025, with completion expected by August 12, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJH72Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,737.35 to AmerisourceBergen Drug Corp for Onfil 10 mg tablets (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside contract employs firm fixed pricing under a delivery order contract type and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as the prime contractor on this award. This delivery order represents a task under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The overarching IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The contract demonstrates AmerisourceBergen Drug Corp's established capability to meet federal pharmaceutical procurement requirements through open competition and its role as a key supplier within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 8/11/25 |